Skip to main content
. 2019 Nov 11;11(11):1771. doi: 10.3390/cancers11111771
Anti-RANKL Anti-Receptor Activator of Ligand
CON Control group
CT Computed tomography
CTCAE Common Terminology Criteria for Adverse Events
CTV Clinical target volume
EORTC European Organization for Research and Treatment of Cancer
3DCRT Conventional 3D conformal radiotherapy
Gy Gray
IC Informed consent
IMRT Intensity-modulated radiotherapy
INT Intervention group
IPMT isometric paravertebral muscle training
MRI Magnetic resonance imaging
OMED Oral morphine equivalent dose
OS Overall survival
PTV Planning target volume
QOL Quality of life
RT Radiotherapy
SBRT stereotactic body radiotherapy
SIB Simultaneously integrated boost
SINS Spinal Instability Neoplastic Score
USM Unstable spine metastases
VAS Visual analog scale
VCF Vertebral compression fracture
VMAT Volumetric modulated arc therapy